Literature DB >> 26781578

Development of a Murine Model with Optimal Routes for Bacterial Infection and Treatment, as Determined with Bioluminescent Imaging in C57BL/6 Mice.

Anneke M Brand1, Rob Smith2, Michele de Kwaadsteniet1, Leon M T Dicks3.   

Abstract

Mice intragastrically infected with Listeria monocytogenes EGDe and Staphylococcus aureus Xen 36 showed no visible signs of infection over 48 h. However, high numbers (6.2 × 10(5) cfu/mg feces) of S. aureus Xen 36 were detected 4 h, and 3.3 × 10(5) cfu/mg feces of L. monocytogenes EGDe 8 h, after administration. Mice intraperitoneally infected with S. aureus Xen 36 (1 × 10(7) cfu) developed infection immediately after administration and for at least the following 48 h. Injection with higher cell numbers of S. aureus Xen 36 (2 × 10(8) cfu) resulted in more intense bioluminescence (infection) of the peritoneal cavity. Injection of S. aureus Xen 36 in the tail and penile veins resulted in localized tissue infection for the first 120 h. Injection of S. aureus Xen 36 into the thigh produced a faint bioluminescent signal for 15 min. Nisin F injected into the peritoneal cavity at the same area of infection led to an immediate statistically significant decrease in infection (from 2 × 10(6) p/s/cm(2)/sr to 3 × 10(5) p/s/cm(2)/sr) within 2 h. Similar results were recorded when nisin F was injected subcutaneously. Intraperitoneal administration is an optimal administration route for bacterial infection and treatment with antimicrobial peptides.

Entities:  

Keywords:  Bioluminescent imaging; Infection model; Staphylococcus aureus

Year:  2011        PMID: 26781578     DOI: 10.1007/s12602-011-9069-4

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  21 in total

1.  Photonic detection of bacterial pathogens in living hosts.

Authors:  C H Contag; P R Contag; J I Mullins; S D Spilman; D K Stevenson; D A Benaron
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

2.  Errors in the technique of intraperitoneal injection of mice.

Authors:  J P Steward; E P Ornellas; K D Beernink; W H Northway
Journal:  Appl Microbiol       Date:  1968-09

3.  Intraperitoneal injection of mice.

Authors:  N A Miner; J Koehler; L Greenaway
Journal:  Appl Microbiol       Date:  1969-02

4.  Evaluation of Nisin F in the Treatment of Subcutaneous Skin Infections, as Monitored by Using a Bioluminescent Strain of Staphylococcus aureus.

Authors:  M de Kwaadsteniet; C A van Reenen; L M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2009-08-13       Impact factor: 4.609

5.  Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodes.

Authors:  C Oussoren; M Velinova; G Scherphof; J J van der Want; N van Rooijen; G Storm
Journal:  Biochim Biophys Acta       Date:  1998-03-13

6.  Novel luciferase reporter system for in vitro and organ-specific monitoring of differential gene expression in Listeria monocytogenes.

Authors:  Peter A Bron; Ian R Monk; Sinéad C Corr; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

7.  Vaccine assembly from surface proteins of Staphylococcus aureus.

Authors:  Yukiko K Stranger-Jones; Taeok Bae; Olaf Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

8.  Characterization of the structural gene encoding nisin F, a new lantibiotic produced by a Lactococcus lactis subsp. lactis isolate from freshwater catfish (Clarias gariepinus).

Authors:  M de Kwaadsteniet; K Ten Doeschate; L M T Dicks
Journal:  Appl Environ Microbiol       Date:  2007-11-26       Impact factor: 4.792

9.  Specific osmolyte transporters mediate bile tolerance in Listeria monocytogenes.

Authors:  Debbie Watson; Roy D Sleator; Pat G Casey; Colin Hill; Cormac G M Gahan
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

10.  Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections.

Authors:  Cynthia L Maree; Robert S Daum; Susan Boyle-Vavra; Kelli Matayoshi; Loren G Miller
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more
  2 in total

Review 1.  Reporter systems for in vivo tracking of lactic acid bacteria in animal model studies.

Authors:  Winschau F van Zyl; Shelly M Deane; Leon M T Dicks
Journal:  Gut Microbes       Date:  2015

2.  In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin against Escherichia coli in a Neutropenic Murine Thigh Infection Model.

Authors:  Yu-Feng Zhou; Meng-Ting Tao; Yu-Zhang He; Jian Sun; Ya-Hong Liu; Xiao-Ping Liao
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.